• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZOLL MANUFACTURING CORPORATION LIFEVEST WCD 4000 SYSTEM; WEARABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZOLL MANUFACTURING CORPORATION LIFEVEST WCD 4000 SYSTEM; WEARABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number LIFEVEST WCD 4000 SYSTEM
Device Problems Inappropriate/Inadequate Shock/Stimulation (1574); Device Sensing Problem (2917); Device Fell (4014)
Patient Problems Bradycardia (1751); Shock from Patient Lead(s) (3162); Asystole (4442)
Event Date 01/02/2023
Event Type  Death  
Manufacturer Narrative
The electrode belt and monitor have been returned and the evaluation is underway.The device flag data from the last download does not indicate any device malfunction.
 
Event Description
A us distributor contacted zoll to report that a patient passed away on (b)(6) 2023 while reportedly wearing the lifevest.The patient received six appropriate treatment, five of which converted the arrhythmias to a slower rhythm and one which did not convert the arrhythmia.The patient also received an inappropriate treatment and a non-lifevest defibrillation.The device was started up at 13:23:13 on (b)(6) 2023.At 01:04:53 on (b)(6) 2023, an arrhythmia was detected.Ecg shows sinus rhythm @ 60 bpm with pvc degrading to vf.At 01:05:54, the patient received the first appropriate treatment.The rhythm at the time of treatment was vf.The post shock rhythm was sinus bradycardia @ 20 bpm with motion/tactile artifact, hb and pvcs.At 01:06:55, an arrhythmia was detected.Ecg shows vf with motion artifact.At 01:07:27, the patient received the second appropriate treatment.The rhythm at the time of treatment was vf with motion artifact.The post shock rhythm was sinus bradycardia @ 30 bpm with motion/tactile artifact, hb and pvcs degrading to vf.At 01:08:45, the patient received the third appropriate treatment.The rhythm at the time of treatment was vf.The post shock rhythm was sinus bradycardia from 15-30 bpm with motion/tactile artifact, hb and pvcs degrading to vf.At 01:09:19, the patient received the fourth appropriate treatment.The rhythm at the time of treatment was vf.The post shock rhythm was vf.At 01:09:52, the patient received the fifth appropriate treatment.The rhythm at the time of treatment was vf.The post shock rhythm was sinus bradycardia @ 40 bpm with pvcs.At 01:10:23, the patient received the first inappropriate treatment.Oversensing of cardiac activity contributed to the false detection.The rhythm at the time of treatment was sinus rhythm @ 90 bpm with pvcs/nsvt.The post shock rhythm was vf.At 01:10:57, the patient received the sixth appropriate treatment.The rhythm at the time of treatment was vf.The post shock rhythm was sinus bradycardia @ 30 bpm with pvcs/nsvt degrading to vf with cpr/motion artifact.At, 01:29:58, the patient received the non-lifevest defibrillation.The rhythm at the time of the non-lifevest defibrillation was vf with cpr/motion artifact.Post shock rhythm was asystole with intermittent cardiac activity and cpr/motion artifact.At 01:34:58, an arrhythmia was detected.Ecg shows asystole with intermittent cardiac activity and cpr/motion artifact.At 01:35:57, the patient received the second inappropriate treatment.Oversensing of cardiac activity contributed to the false detection.The patient was in a non-life sustaining rhythm prior to the treatment.The rhythm at the time of treatment was asystole with intermittent cardiac activity and cpr/motion artifact.The post shock rhythm continued to be in asystole, which is a non-life sustaining rhythm, with motion artifact and electrode lead falloff.The electrode belt was disconnected at 1:36:22 on (b)(6) 2023.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIFEVEST WCD 4000 SYSTEM
Type of Device
WEARABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
ZOLL MANUFACTURING CORPORATION
121 gamma drive
pittsburgh PA 15238
Manufacturer (Section G)
ZOLL MANUFACTURING CORPORATION
121 gamma drive
pittsburgh PA
Manufacturer Contact
zoll mfg corporation
121 gamma drive
pittsburgh, PA 15238
MDR Report Key16273059
MDR Text Key308492351
Report Number3008642652-2023-00994
Device Sequence Number1
Product Code MVK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Distributor
Reporter Occupation Other
Type of Report Initial
Report Date 01/30/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/31/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberLIFEVEST WCD 4000 SYSTEM
Date Manufacturer Received01/04/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Death;
-
-